title: Different doses of epirubicin associated with fixed doses of cyclophosphamide and 5-fluorouracil: a randomised study in advanced breast cancer.
authors.forename: A
authors.initials: A
authors.lastname: Riccardi
authors.forename: M
authors.initials: M
authors.lastname: Giordano
authors.forename: S
authors.initials: S
authors.lastname: Brugnatelli
authors.forename: G
authors.initials: G
authors.lastname: Ucci
authors.forename: M
authors.initials: M
authors.lastname: Danova
authors.forename: O
authors.initials: O
authors.lastname: Mora
authors.forename: S
authors.initials: S
authors.lastname: Fava
authors.forename: E
authors.initials: E
authors.lastname: Ascari
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000008:administration & dosage; D015251:Epirubicin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008875:Middle Aged; D016896:Treatment Outcome
chemical_list: D015251:Epirubicin; D003520:Cyclophosphamide; D005472:Fluorouracil